Efficacy of Salivary Bacteria and Post Brushing

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00981825
Recruitment Status : Completed
First Posted : September 22, 2009
Results First Posted : September 22, 2009
Last Update Posted : June 14, 2011
Information provided by:
Colgate Palmolive

September 26, 2008
September 22, 2009
September 26, 2008
September 22, 2009
June 14, 2011
October 2007
December 2007   (Final data collection date for primary outcome measure)
CFU (Colony Forming Units) [ Time Frame: 4 hours ]
Total number of salivary bacterial colony forming units (lower number = less colonies present)
CFU (Colony Forming Units) [ Time Frame: 4 hours ]
Complete list of historical versions of study NCT00981825 on Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Efficacy of Salivary Bacteria and Post Brushing
Efficacy of Salivary Bacteria and Post Brushing
Research study to compare the effects of brushing with two commercially available toothpastes on salivary bacteria after brushing
Not Provided
Phase 3
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Salivary Bacteria Levels
  • Drug: Fluoride
    Whole mouth brushing for 7 days
    Other Name: fluoride toothpaste (Colgate Great Regular Flavor toothpaste)
  • Drug: Triclosan/Fluoride
    Brush whole mouth twice daily for 7 days
    Other Name: triclosan/fluoride toothpaste (Colgate Total toothpaste)
  • Placebo Comparator: A
    fluoride toothpaste control
    Intervention: Drug: Fluoride
  • Active Comparator: B
    triclosan/fluoride toothpaste
    Intervention: Drug: Triclosan/Fluoride
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Same as current
December 2007
December 2007   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Male or female volunteers 18-65 years of age
  • Good general health
  • Must sign informed consent form
  • Must discontinue oral hygiene on the mornings of each appointment and between sampling periods.
  • No history of allergy to personal care consumer products, or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study.

Exclusion Criteria:

  • Medical condition which requires pre-medication prior to dental procedures/visits
  • Medical condition which precludes eating/drinking for 12 hrs.
  • History of allergy to common dentifrice ingredients
  • Subjects unable or unwilling to sign the informed consent form.
  • Moderate or advanced periodontal disease.
  • 2 or more decayed untreated dental sites at screening.
  • Other disease of the hard or soft oral tissues.
  • Impaired salivary function (e.g. Sjogren's syndrome or head and neck irradiation).
  • Use of medications that can currently affect salivary flow
  • Current use of antibiotics
  • Use of antibiotics or antimicrobial drugs within 30 days prior to study visit #1.
  • Pregnant or nursing women.
  • Participation in any other clinical study within 30 days prior to enrollment into this study.
  • Use of tobacco products
  • Subjects who must receive dental treatment during the study dates.
  • Current use of Antibiotics for any purpose.
  • Immune compromised individuals (HIV,AIDS, immuno suppressive drug therapy)
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
William DeVizio/VP - Clinical Research, Colgate Palmolive
Colgate Palmolive
Not Provided
Principal Investigator: Neelim Utgikar, DDS
Colgate Palmolive
June 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP